"Providing state-of-the-art, world-class eye care."

During the past decade, University of California, Davis, Eye Center conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 7 clinical trials were completed, i.e. on average, 116.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 5 clinical trials were completed. i.e. 250% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of California, Davis, Eye Center" #1 collaborator was "University of California, San Francisco" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "University of California, Davis, Eye Center" are "Geographic Atrophy" (2 trials), "Ocular Hypertension" (2 trials), "Primary Open-Angle Glaucoma" (2 trials), "Diabetic Macular Edema" (1 trials) and "Exudative Age-related Macular Degeneration" (1 trials). Many other conditions were trialed in "University of California, Davis, Eye Center" in a lesser frequency.

Most popular intervention types in "University of California, Davis, Eye Center" are "Drug" (8 trials), "Other" (2 trials), "Procedure" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Faricimab" (3 trials), "Sham Procedure" (3 trials), "Aflibercept" (2 trials), "Bimatoprost" (2 trials) and "Lampalizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "University of California, Davis, Eye Center" are 8 trials for "All" genders.

Currently, there are NaN active trials in "University of California, Davis, Eye Center". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in University of California, Davis, Eye Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in University of California, Davis, Eye Center, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".